$ETH $XRP $BMT In the USA, an injection for HIV prevention has been approved — details

The U.S. Food and Drug Administration (FDA) has approved the drug Yeztugo (lenacapavir) for HIV prevention. According to the developers, the injection can be administered twice a year.

"This is a historic day in the long fight against HIV. Yeztugo is one of the most important scientific breakthroughs of our time, offering a real opportunity to help end the HIV epidemic," said Daniel O'Day, Chairman and CEO of Gilead Sciences.

According to the FDA, the drug called lenacapavir almost completely eliminates the risk of new infections in high-risk individuals and proved to be better than other preventive methods. Greg Millet, Director of Public Policy at amfAR, The Foundation for AIDS Research, believes that the vaccine could "put an end to the transmission of HIV."

At the same time, Millet pointed to issues within the U.S. healthcare system and globally that could hinder not only providing people with the vaccine but also ensuring they return for their next shot in six months.